期刊文献+

益气泻肺冲剂治疗慢性心力衰竭的临床观察 被引量:4

Clinical Observation on Yiqi Xiefei Granule in Treating Chronic Heart Failure
下载PDF
导出
摘要 目的:观察比较益气泻肺冲剂与西药治疗慢性心力衰竭(CHF)的临床疗效。方法:选取2011年1月至2013年12月期间在北京市昌平区中医医院心血管病科确诊为慢性心力衰竭(CHF)的患者70例,随机分为对照组和观察组,每组35例。对照组按西医常规治疗方案进行治疗;观察组则在对照组基础上,根据辨证加用中药益气泻肺冲剂加减进行治疗。观察治疗前后心力衰竭患者的临床症状、体征、心肺运动试验(CPET)后指标、左室射血分数(LVEF)、左室舒张末径值(LVED)及血浆NT-pro BNP水平。结果:治疗后,观察组症状积分及体征积分均低于对照组,其差异有统计学意义(P<0.05);2组患者治疗后LVEF上升、LVED下降、血浆NT-pro BNP水平下降,观察组LVEF上升、NT-pro BNP指标下降较对照组明显(P<0.05);观察组CPET试验结果(峰值氧耗量、无氧阈)提高,较对照组明显(P<0.05)。结论:益气泻肺冲剂能够有效改善慢性心力衰竭(CHF)患者的证候、临床症状,改善患者心功能。 Objective: To observe the clinical efficacy of Yiqi Xiefei granule in the treatment of chronic heart failure (CHF). Methods:Seventy patients with chronic heart failure (CHF) were randomly divided into control group (n =35 ) and treatment group ( n = 35 ). The control group was treated with routine western medicine. The treatment group was treated with traditional Chi- nese medicine Yiqi Xiefei granule on the basis of routine western treatment. Left ventricular ejection fraction (LVEF) , left ventricular end diastolic diameter (LVED) and NT-proBNP were measured before and after treatment. Clinical symptoms, signs, car- diopulmonary exercise test (CPET) results were recorded. Results:After treatment, symptom scores and signs scores of the treat- ment group were significantly lower than those of the control group ( P 〈 0. 05 ). After treatment, LVEF increased, LVED de- creased, NT-proBNP decreased, LVEF increased, NT-proBNP in both groups (P 〈 0. 05). After treatment, CPET (peak oxygen consumption, anaerobic threshold) in the treatment group were significantly higher than those in the control group ( P 〈 0. 05 ). Conclusion:Yiqi Xiefei granule can effectively improve the symptoms of patients with chronic heart failure (CHF) as well as cardiac function.
作者 郭学军
出处 《世界中医药》 CAS 2017年第6期1302-1305,共4页 World Chinese Medicine
关键词 益气泻肺冲剂 慢性心力衰竭 临床观察 Yiqi Xiefei granule Congestive Heart Failure Clinical Observation
  • 相关文献

参考文献6

二级参考文献72

  • 1王方正,张澍,黄德嘉,华伟,孙宝贵,沈法荣,吴书林,王建安,方全,吴立群,王景峰,王冬梅,郭涛,陈新,中华医学会心电生理和起搏分会心脏再同步治疗专家工作组.心脏再同步治疗慢性心力衰竭的建议[J].中华心律失常学杂志,2006,10(2):90-102. 被引量:90
  • 2虞准,宋雪,甘辉立,田小园.参麦注射液治疗冠脉搭桥术后合并左心功能不全的疗效观察[J].华中医学杂志,2006,30(3):227-228. 被引量:7
  • 3郑筱荑.中药新药临床研究指导原则[M].北京:中国医药科技出版社,2002:78.
  • 4Colucci WS. Molecular and cellular mechanisms of myocardial failure. Am J Cardiol, 1997, 80(11A) : 15L-25L
  • 5Braunwald E,Bristow MR Congestive heart failure: fifty years of progress. Circulation, 2000, 102(20 Suppl 4) : Ⅳ14-23.
  • 6Hunt SA, Abraham WT, Chin MH, et al. ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure) : developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society. Circulation, 2005, 112 (12) :e154-235.
  • 7Swedberg K, Cleland J, Dargie H, et al. Guidelines for the diagnosis and treatment of chronic heart failure: executive summary ( update 2005 ):The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Eur Heart J, 2005, 26(11): 1115-1140.
  • 8Arnold JM, Liu P, Demers C, et al. Canadian Cardiovascular Society consensus conference recommendations on heart failure 2006 : diagnosis and management. Can J Cardiol, 2006, 22 (1): 23-45.
  • 9Heart Failure Society of America. HFSA 2006 Comprehensive Heart Failure Practice Guideline. J Card Fail, 2006, 12 ( 1 ) : e1-2.
  • 10Enright PL, Sherrill DL Reference equations for the six-minute walk in healthy adults. Am J Respir Crit Care Med, 1998, 158(5 pt 1) :1384-1387.

共引文献3758

同被引文献27

引证文献4

二级引证文献35

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部